공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 관절염용 단클론항체 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년)

Arthritis Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028938
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,919,000 PDF (Single User License)
US $ 7,500 ₩ 8,878,000 PDF (Site License)
US $ 10,000 ₩ 11,838,000 PDF (Enterprise License)


세계의 관절염용 단클론항체 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년) Arthritis Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 관절염용 단클론항체(Arthritis Monoclonal Antibodies) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모 추이와 예측, 약제·용도·최종사용자·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 개요, 향후 전망 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 COVID-19의 영향

제5장 시장 규모 및 성장 예측

  • 시장 규모 추이와 예측
  • 성장 촉진요인
  • 성장 억제요인

제6장 시장 분석과 예측 : 각종 구분별

  • 약제별
    • Remicade
    • Humira
    • Enbrel
    • Rituxan
    • Orencia
    • Actemra
    • Simponi
    • Cimzia
    • Remsima
  • 용도별
    • 류마티스 관절염
    • 골관절염
    • 건선성 관절염
    • 강직성 척추염
    • 섬유근육통
    • 기타
  • 최종사용자별
    • 병원
    • 연구기관
    • 기타

제7장 시장 분석과 예측 : 지역/국가별

제8장 아시아태평양 시장 분석과 예측

  • 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 법규제, 기관&협회, 조세, 투자, 주요 기업
  • 시장 분석과 예측 : 약제별
  • 시장 분석과 예측 : 용도별

제9장 중국 시장 분석과 예측

제10장 인도 시장 분석과 예측

제11장 일본 시장 분석과 예측

제12장 호주 시장 분석과 예측

제13장 인도네시아 시장 분석과 예측

제14장 한국 시장 분석과 예측

제15장 서유럽 시장 분석과 예측

제16장 영국 시장 분석과 예측

제17장 독일 시장 분석과 예측

제18장 프랑스 시장 분석과 예측

제19장 동유럽 시장 분석과 예측

제20장 러시아 시장 분석과 예측

제21장 북미 시장 분석과 예측

제22장 미국 시장 분석과 예측

제23장 남미 시장 분석과 예측

제24장 브라질 시장 분석과 예측

제25장 중동 시장 분석과 예측

제26장 아프리카 시장 분석과 예측

제27장 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Johnson & Johnson
    • Roche
    • Novartis
    • Pfizer Inc
    • AbbVie Inc.

제28장 파이프라인 분석

제28장 주요 인수합병(M&A)

제29장 향후 전망과 잠재성 분석

제30장 부록

LSH 21.10.06

Arthritis Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global arthritis monoclonal antibodies (mab's) market.

This report focuses on arthritis monoclonal antibodies (mab's) market which is experiencing strong growth. The report gives a guide to the arthritis monoclonal antibodies (mab's) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the arthritis monoclonal antibodies (mab's)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Arthritis Monoclonal Antibodies (mab's) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider arthritis monoclonal antibodies (mab's) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The arthritis monoclonal antibodies (mab's) market section of the report gives context. It compares the arthritis monoclonal antibodies (mab's) market with other segments of the arthritis monoclonal antibodies (mab's) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, arthritis monoclonal antibodies (mab's) indicators comparison.

Scope

Markets Covered: 1) By Drug: Remicade; Humira; Enbrel; Rituxan; Orencia; Actemra; Simponi; Cimzia; Remsima

2) By Application: Rheumatoid Arthritis; Osteoarthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Fibromyalgia; Others

3) By End-Use: Hopitals; Research Institutes; Others

Companies Mentioned: Johnson & Johnson; Roche; Novartis; Pfizer Inc; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Arthritis Monoclonal Antibodies Market Characteristics

3. Arthritis Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Arthritis Monoclonal Antibodies

5. Arthritis Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Arthritis Monoclonal Antibodies Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Arthritis Monoclonal Antibodies Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Arthritis Monoclonal Antibodies Market Segmentation

  • 6.1. Global Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Remicade
  • Humira
  • Enbrel
  • Rituxan
  • Orencia
  • Actemra
  • Simponi
  • Cimzia
  • Remsima
  • 6.2. Global Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Fibromyalgia
  • Others
  • 6.3. Global Arthritis Monoclonal Antibodies Market, Segmentation By End-use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hopitals
  • Research Institutes
  • Others

7. Arthritis Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Arthritis Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Arthritis Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Arthritis Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Arthritis Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Arthritis Monoclonal Antibodies Market

  • 9.1. China Arthritis Monoclonal Antibodies Market Overview
  • 9.2. China Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Arthritis Monoclonal Antibodies Market

  • 10.1. India Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Arthritis Monoclonal Antibodies Market

  • 11.1. Japan Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Arthritis Monoclonal Antibodies Market

  • 12.1. Australia Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Arthritis Monoclonal Antibodies Market

  • 13.1. Indonesia Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Arthritis Monoclonal Antibodies Market

  • 14.1. South Korea Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Arthritis Monoclonal Antibodies Market

  • 15.1. Western Europe Arthritis Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Arthritis Monoclonal Antibodies Market

  • 16.1. UK Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Arthritis Monoclonal Antibodies Market

  • 17.1. Germany Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Arthritis Monoclonal Antibodies Market

  • 18.4. France Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Arthritis Monoclonal Antibodies Market

  • 19.1. Eastern Europe Arthritis Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Arthritis Monoclonal Antibodies Market

  • 20.1. Russia Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Arthritis Monoclonal Antibodies Market

  • 21.1. North America Arthritis Monoclonal Antibodies Market Overview
  • 21.2. North America Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Arthritis Monoclonal Antibodies Market

  • 22.1. USA Arthritis Monoclonal Antibodies Market Overview
  • 22.2. USA Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Arthritis Monoclonal Antibodies Market

  • 23.1. South America Arthritis Monoclonal Antibodies Market Overview
  • 23.2. South America Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Arthritis Monoclonal Antibodies Market

  • 24.1. Brazil Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Arthritis Monoclonal Antibodies Market

  • 25.1. Middle East Arthritis Monoclonal Antibodies Market Overview
  • 25.2. Middle East Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Arthritis Monoclonal Antibodies Market

  • 26.1. Africa Arthritis Monoclonal Antibodies Market Overview
  • 26.2. Africa Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Arthritis Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Arthritis Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Arthritis Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Johnson & Johnson
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Roche
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Pfizer Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. AbbVie Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Arthritis Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Arthritis Monoclonal Antibodies Market

30. Arthritis Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q